Cargando…
SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic
Surgical resection is the standard-of-care approach for early-stage non-small cell lung cancer (NSCLC). Surgery is also considered an acceptable standard infit patients with oligometastatic lesions in the lungs. The COVID-19 pandemic has led to worldwide issues with access to operating room time, wi...
Autores principales: | Kidane, Biniam, Spicer, Jonathan, Kim, Julian O., Fiset, Pierre-Olivier, Abdulkarim, Bassam, Malthaner, Richard, Palma, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544973/ https://www.ncbi.nlm.nih.gov/pubmed/33072612 http://dx.doi.org/10.3389/fonc.2020.580189 |
Ejemplares similares
-
OA06.07 Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
por: Kidane, B., et al.
Publicado: (2022) -
Bayesian AVO inversion
por: Buland, A, et al.
Publicado: (2001) -
Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016) -
First person – Wei-Lun Hsu
Publicado: (2023) -
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
por: Olson, Robert, et al.
Publicado: (2018)